Skip to content
Screener
Q4 '26Q3 '26Q2 '26Q1 '26Q4 '25
-$20.62M+24.0%-$35.05M-272%-$44.02M-11.9%-$30.51M+3.4%-$27.14M+21.7%
$7.1M+18.2%$6.78M+11.8%$6.41M+0.2%$6.19M-2.9%$6M-9.8%
$19.47M+21.1%$18.18M+13.2%$18.94M-6.8%$13.27M+10.7%$16.08M+30.3%
-$173K+98.5%——-$17.56M-35.2%-$24.81M-15.8%-$11.81M+22.9%
$19.96M+60.6%$9.76M+6.5%$7.89M+90.3%$9.97M+340%$12.43M+521%
-$20.25M-63.3%-$10.2M-8.5%-$12.71M-791%-$9.93M-547%-$12.4M-865%
$0—$0—$0—$0-100%——
$438.46M+7,766%$3.79M+107%$4.14M+29.5%$298K-98.3%$5.57M+53.7%
$418.04M+2,362%-$5.29M+41.5%-$26.13M-135%-$34.44M-579%-$18.48M-43.2%
-$20.13M+17.0%-$8.65M+18.1%-$25.45M-48.5%-$34.79M-46.8%-$24.24M-39.9%

FAQ

What is Twist Bioscience Corporation's free cash flow?
After $47.6M of capital expenditures, Twist Bioscience Corporation's free cash flow was -$89.0M over the trailing twelve months, down 17.7% year over year.
Where does Twist Bioscience Corporation's cash flow data come from?
Every line is extracted from Twist Bioscience Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.